{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:40:25Z","timestamp":1787902825971,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP203350"],"award-info":[{"award-number":["RP203350"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["P50CA221707"],"award-info":[{"award-number":["P50CA221707"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["1R01CA214793"],"award-info":[{"award-number":["1R01CA214793"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["5P01CA11796"],"award-info":[{"award-number":["5P01CA11796"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"AACR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT94252311082"],"award-info":[{"award-number":["HT94252311082"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0598"],"award-info":[{"award-number":["W81XWH-20-1-0598"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["16-70-25-YAO"],"award-info":[{"award-number":["16-70-25-YAO"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011711","name":"Pancreatic Cancer Action","doi-asserted-by":"publisher","award":["19-65-YAO"],"award-info":[{"award-number":["19-65-YAO"]}],"id":[{"id":"10.13039\/100011711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA221707"],"award-info":[{"award-number":["P50CA221707"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA2888804"],"award-info":[{"award-number":["R21CA2888804"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P01CA11796"],"award-info":[{"award-number":["5P01CA11796"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA220236"],"award-info":[{"award-number":["R01CA220236"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA214793"],"award-info":[{"award-number":["1R01CA214793"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002576","name":"American Cyronics Society","doi-asserted-by":"publisher","award":["R21CA2888804"],"award-info":[{"award-number":["R21CA2888804"]}],"id":[{"id":"10.13039\/100002576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xcrm.2025.102253","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:35:42Z","timestamp":1753454142000},"page":"102253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers"],"prefix":"10.1016","volume":"6","author":[{"given":"Madelaine S.","family":"Theardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zecheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Kanikarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadara","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Paku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Citron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tomihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela K.","family":"Deem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Hanash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"DePinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio F.","family":"Draetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqiang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kopetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-7530","authenticated-orcid":false,"given":"Wantong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102253_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS Proteins and Their Regulators in Human Disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8290.CD-19-1167","article-title":"The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients","volume":"10","author":"Hallin","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102253_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib4","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired Resistance to KRAS(G12C) Inhibition in Cancer","volume":"384","author":"Awad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102253_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1158\/1078-0432.CCR-18-0368","article-title":"KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition","volume":"25","author":"Misale","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1158\/1078-0432.CCR-19-3523","article-title":"Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS(G12C) Inhibition","volume":"26","author":"Ryan","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib7","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1016\/j.celrep.2020.03.021","article-title":"Defining and Targeting Adaptations to Oncogenic KRAS(G12C) Inhibition Using Quantitative Temporal Proteomics","volume":"30","author":"Santana-Codina","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102253_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-021-04065-2","article-title":"Diverse alterations associated with resistance to KRAS(G12C) inhibition","volume":"599","author":"Zhao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cell.2014.06.003","article-title":"Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer","volume":"158","author":"Kapoor","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2014.06.004","article-title":"KRAS and YAP1 converge to regulate EMT and tumor survival","volume":"158","author":"Shao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130811","article-title":"YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma","volume":"4","author":"Tu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102253_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1062-1","article-title":"Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer","volume":"568","author":"Yao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1126\/science.3090687","article-title":"Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins","volume":"233","author":"Bar-Sagi","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102253_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib15","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/srep02385","article-title":"Dissecting the roles of Rac1 activation and deactivation in macropinocytosis using microscopic photo-manipulation","volume":"3","author":"Fujii","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102253_bib16","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/0008-5472.CAN-20-3792","article-title":"Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition","volume":"81","author":"Yan","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) Inhibition with Sotorasib in Advanced Solid Tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102253_bib19","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for Lung Cancers with KRAS p.G12C Mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102253_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/2159-8290.CD-21-0365","article-title":"Clinical Acquired Resistance to KRAS(G12C) Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation","volume":"11","author":"Tanaka","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102253_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-019-1884-x","article-title":"Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition","volume":"577","author":"Xue","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib22","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1158\/1078-0432.CCR-20-2077","article-title":"Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung Cancer","volume":"26","author":"Adachi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1158\/2159-8290.CD-20-0187","article-title":"EGFR Blockade Reverts Resistance to KRAS(G12C) Inhibition in Colorectal Cancer","volume":"10","author":"Amodio","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102253_bib24","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/1078-0432.CCR-21-0856","article-title":"KRAS Inhibitor Resistance in MET-Amplified KRAS (G12C) Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms","volume":"27","author":"Suzuki","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155523","article-title":"Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition","volume":"132","author":"Tsai","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102253_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201414","article-title":"SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling","volume":"218","author":"Fedele","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102253_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2012.02.053","article-title":"Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer","volume":"149","author":"Duncan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib29","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1158\/0008-5472.CAN-16-0232","article-title":"Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth","volume":"76","author":"Beauvais","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V99.4.1405","article-title":"Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma","volume":"99","author":"Derksen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102253_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1097-4652(199803)174:3<310::AID-JCP5>3.0.CO;2-R","article-title":"The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity","volume":"174","author":"Filla","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.xcrm.2025.102253_bib32","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1038\/sj.onc.1209699","article-title":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma","volume":"25","author":"Mahtouk","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2025.102253_bib33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.onc.1209930","article-title":"Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development","volume":"26","author":"McDermott","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2025.102253_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canlet.2014.06.008","article-title":"Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells","volume":"351","author":"Qian","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2025.102253_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-020-14928-3","article-title":"Macropinocytosis confers resistance to therapies targeting cancer anabolism","volume":"11","author":"Jayashankar","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.xcrm.2025.102253_bib50","doi-asserted-by":"crossref","first-page":"110993","DOI":"10.1016\/j.celrep.2022.110993","article-title":"KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12Cinhibitor efficacy","volume":"39","author":"Ryan","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102253_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk0850","article-title":"Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer","volume":"384","author":"Klomp","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102253_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2018.08.009","article-title":"Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS","volume":"34","author":"Kitajima","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102253_bib39","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/0008-5472.CAN-20-1810","article-title":"Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling","volume":"81","author":"Oh","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s43018-023-00575-2","article-title":"Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS","volume":"4","author":"Adachi","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102253_bib41","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-23-2994","article-title":"TEAD Inhibition Overcomes YAP1\/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors","volume":"83","author":"Edwards","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005049","article-title":"Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2025.102253_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/MCB.26.1.77-87.2006","article-title":"Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65","volume":"26","author":"Morin-Kensicki","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102253_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the Roots of Cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102253_bib45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102253_bib46","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102253_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2615","article-title":"ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67","volume":"12","author":"Tuominen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102253_bib48","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","article-title":"Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells","volume":"5","author":"Tibes","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2025.102253_bib49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1158\/1535-7163.MCT-16-0721","article-title":"Modeling of Patient-Derived Xenografts in Colorectal Cancer","volume":"16","author":"Katsiampoura","year":"2017","journal-title":"Mol. Cancer Ther."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912500326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912500326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:50Z","timestamp":1778919530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912500326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S266637912500326X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102253","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102253"}}